Large Molecule Drug Substance Development is seeking an accomplished scientific leader to direct the strategy and execution of biologics drug substance programs at the Rahway, New Jersey site. The role combines cross-functional CMC program leadership with expertise in cell line, upstream, and downstream process development; scale-up; technology transfer; and clinical manufacturing. The leader will advance assigned biologics from candidate selection through early clinical development and First-in-Human milestones while establishing robust, phase-appropriate processes that enable late-stage development and commercialization. The role is accountable for drug substance manufacturing process development and in-process control strategies, transfer of processes to GMP manufacturing sites, and reliable delivery of clinical drug substance supply. The successful candidate will be an enterprise-minded matrix leader who combines scientific judgment with disciplined execution. They will align cross-functional teams, anticipate and mitigate program risks, communicate with senior stakeholders, and deliver innovative, scalable, and compliant drug substance solutions. The position leads assigned early-stage Development and Commercialization Teams (DCTs), with accountability for integrated CMC strategy, milestone readiness, cross-functional alignment, and advancement through governance decisions. It defines phase-appropriate drug substance strategies and leads or supports drug substance content for global regulatory submissions. The role also coaches scientists and functional leads, and leads improvements that accelerate FIH timelines, strengthen platform approaches, and expand use of advanced process technologies, modeling, automation, and digital tools.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Principal
Education Level
Ph.D. or professional degree